Breast Cancer Clinical Trials
Find clinical trials for breast cancer. Search for breast cancer clinical trials in different cities and states across the United States.
Prognostic Indicators for Radiation-induced Breast FibrosisPrognostic Indicators for Radiation-induced Breast Fibrosis
Sponsor:
AHS Cancer Control Alberta
Location:
Code:
NCT05031065
Conditions
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 40+
Healthy Volunteers: Not accepted
Interventions
Breast Cancer Radiotherapy
Study of LP-184 in Patients with Advanced Solid TumorsStudy of LP-184 in Patients with Advanced Solid Tumors
Sponsor:
Lantern Pharma Inc.
Location:
Code:
NCT05933265
Conditions
Advanced Solid Tumor
Metastatic Solid Tumor
GBM
TNBC - Triple-Negative Breast Cancer
NSCLC
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
LP-184
Spironolactone
Olaparib
Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast CancerTumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer
Sponsor:
Thomas Jefferson University
Location:
Code:
NCT01514565
Conditions
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistrySYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Sponsor:
Massive Bio, Inc.
Location:
Code:
NCT03452774
Conditions
Cancer, Metastatic
Cancer
Cancer of Pancreas
Cancer of Liver
Cancer of Stomach
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Clinical Trial Matching
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast CancerDecision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Sponsor:
M.D. Anderson Cancer Center
Location:
Code:
NCT02918474
Conditions
Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage IA Breast Cancer AJCC v8
Anatomic Stage IB Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Anatomic Stage IIA Breast Cancer AJCC v8
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Decision Aid
Questionnaire Administration
Post-Mastectomy Analgesia Using Exparel (Liposomal) Versus Standard Bupivacaine or PlaceboPost-Mastectomy Analgesia Using Exparel (Liposomal) Versus Standard Bupivacaine or Placebo
Sponsor:
Georgetown University
Location:
Code:
NCT03504865
Conditions
Mastectomy
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Liposomal bupivacaine
Standard bupivacaine
Placebo
Study Assessing QBS72S for Treating Brain MetastasesStudy Assessing QBS72S for Treating Brain Metastases
Sponsor:
Melanie Hayden Gephart
Location:
Code:
NCT05305365
Conditions
Brain Metastases
Breast Cancer
Lung Cancer
Leptomeningeal Disease
LMD
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
QBS72S
A Study of NX-1607 in Adults With Advanced MalignanciesA Study of NX-1607 in Adults With Advanced Malignancies
Sponsor:
Nurix Therapeutics, Inc.
Location:
Code:
NCT05107674
Conditions
Ovarian Cancer, Epithelial
Gastric Cancer
GastroEsophageal Junction (GEJ) Cancer
Head and Neck Squamous Cell Carcinoma
Metastatic or Unresectable Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
NX-1607
Paclitaxel
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Sponsor:
Merck Sharp & Dohme LLC
Location:
Code:
NCT06393374
Conditions
Triple-Negative Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Pembrolizumab
Sacituzumab tirumotecan
Capecitabine
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBCNeoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC
Sponsor:
University of Kansas Medical Center
Location:
Code:
NCT05645380
Conditions
Triple Negative Breast Cancer
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Carboplatin
Docetaxel
Doxorubicin
Cyclophosphamide
Pembrolizumab